On Monday, Thermo Fisher Scientific Inc (NYSE: TMO) opened lower -0.30% from the last session, before settling in for the closing price of $423.55. Price fluctuations for TMO have ranged from $409.85 to $627.88 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 11.57%. Company’s average yearly earnings per share was noted 2.06% at the time writing. With a float of $376.83 million, this company’s outstanding shares have now reached $377.49 million.
Let’s determine the extent of company efficiency that accounts for 125000 employees. In terms of profitability, gross margin is 41.74%, operating margin of 17.08%, and the pretax margin is 16.48%.
Thermo Fisher Scientific Inc (TMO) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Diagnostics & Research industry is another important factor to consider. The insider ownership of Thermo Fisher Scientific Inc is 0.17%, while institutional ownership is 91.57%. The most recent insider transaction that took place on Apr 28 ’25, was worth 128,979. In this transaction Executive Vice President of this company sold 300 shares at a rate of $429.93, taking the stock ownership to the 23,167 shares. Before that another transaction happened on Apr 28 ’25, when Company’s Officer proposed sale 300 for $429.93, making the entire transaction worth $128,979.
Thermo Fisher Scientific Inc (TMO) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 2.06% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 7.99% during the next five years compared to 12.52% growth over the previous five years of trading.
Thermo Fisher Scientific Inc (NYSE: TMO) Trading Performance Indicators
Check out the current performance indicators for Thermo Fisher Scientific Inc (TMO). In the past quarter, the stock posted a quick ratio of 1.38. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.72. Likewise, its price to free cash flow for the trailing twelve months is 23.71.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 17.04, a number that is poised to hit 5.23 in the next quarter and is forecasted to reach 24.69 in one year’s time.
Technical Analysis of Thermo Fisher Scientific Inc (TMO)
Looking closely at Thermo Fisher Scientific Inc (NYSE: TMO), its last 5-days average volume was 2.66 million, which is a jump from its year-to-date volume of 2.23 million. As of the previous 9 days, the stock’s Stochastic %D was 14.11%. Additionally, its Average True Range was 15.36.
During the past 100 days, Thermo Fisher Scientific Inc’s (TMO) raw stochastic average was set at 6.17%, which indicates a significant decrease from 14.90% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 22.05% in the past 14 days, which was lower than the 31.38% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $480.31, while its 200-day Moving Average is $547.80. However, in the short run, Thermo Fisher Scientific Inc’s stock first resistance to watch stands at $425.55. Second resistance stands at $428.83. The third major resistance level sits at $432.67. If the price goes on to break the first support level at $418.43, it is likely to go to the next support level at $414.58. Now, if the price goes above the second support level, the third support stands at $411.30.
Thermo Fisher Scientific Inc (NYSE: TMO) Key Stats
There are currently 377,492K shares outstanding in the company with a market cap of 159.40 billion. Presently, the company’s annual sales total 42,879 M according to its annual income of 6,335 M. Last quarter, the company’s sales amounted to 10,364 M and its income totaled 1,507 M.
